Wellnex Collagen Peptides Demonstrate Promising Role in Management of Type 2 Diabetes

April, 2018 – A double-blind, randomized, human clinical study evaluating the effectiveness of Wellnex collagen peptides as an add-on nutritional supplement for those with Type 2 Diabetes, found promising results over the 90-day trial. According to the published study, a significant reduction in fasting blood glucose and HbA1C was observed in subjects who have taken 10g/day collagen peptides orally over the duration of the study. Insulin sensitivity measured in as HOMA IR was also significantly improved in the collagen peptide group over the placebo group. This study demonstrates the potential role of collagen peptides as add-on nutritional supplement for the management of Type 2 Diabetes.